MEHARRY MEDICAL COLLEGE

Clinical Trial Diversity Crisis: Dr. Karen Winkfield Outlines Solutions for Inclusive Patient Participation

3 months ago

• Clinical trial participation faces major barriers, with trial unavailability and lack of physician referrals identified as primary obstacles to patient enrollment in research studies. • Vanderbilt's NCI-designated cancer center is implementing AI-driven screening systems to match eligible patients with clinical trials, addressing the challenge of comprehensive patient screening. • The Meharry-Vanderbilt Alliance, partnering with a historically Black medical institution, focuses on building community trust and expanding trial access through education and local support networks.

Vanderbilt Cancer Expert Emphasizes Community-Centered Approach to Improve Healthcare Access

4 months ago

• Dr. Karen Winkfield, Ingram Professor at Vanderbilt, highlights the critical need to recognize healthcare is not one-size-fits-all, especially for underserved communities facing unique access challenges. • Healthcare providers must focus on relationship building and cultural humility to establish trust with diverse patient populations and ensure effective cancer care delivery. • Community engagement and clear communication of medical research are essential for building public trust and ensuring equitable access to cancer treatment innovations.

Sanofi Invests $18 Million to Boost Diversity in Clinical Trials at Black Medical Schools

7 months ago

• Sanofi is investing $18 million over 10 years in three Historically Black Medical Schools (HBMCs) to establish Centers of Excellence for clinical study diversity. • The initiative aims to address the underrepresentation of Black individuals in clinical research, ensuring treatments are effective and safe for Black patients. • Funding will support hiring clinical research staff, upgrading infrastructure, and developing customized training programs at Howard, Meharry, and Morehouse. • The investment aligns with the FDA mandate for diversity in clinical trials, promoting equitable healthcare interventions and trust within Black communities.